Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions

Authors:

9 April 2019

journal article
letter
Published by American Medical Association (AMA) in JAMA

Vol. 321 (14) , 1407-1408
DOI:10.1001/jama.2019.0834
PMID:30964519
PMCID:PMC6459110

Abstract

This study uses SAMHSA data to describe the proportions of nurse practitioners and physician assistants with waivers to prescribe buprenorphine for treating opi

Keywords

BUPRENORPHINE
NURSE PRACTITIONER
PHYSICIAN ASSISTANT
WAIVERS
SCOPE OF PRACTICE
OPIOID USE DISORDERS

This publication has 2 references indexed in Scilit:

30th Annual APRN Legislative Update
The Nurse Practitioner, 2018
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
American Journal of Public Health, 2015